Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Acute Ischemic Stroke (AIS)
Hypertension
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
26 Jul 2023
JIXING Announces the Acceptance of the Clinical Trial Application for the Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy by the National Medical Products Administration
Read article
18 Jul 2023
JIXING Announces Positive Topline Results from China Phase 3 Study for Ophthalmology Product Varenicline Solution Nasal Spray
Read article
17 Jul 2023
JIXING Announces NMPA Acceptance of New Drug Application for Varenicline Solution Nasal Spray
Read article
12 Jul 2023
JIXING and TSH Biopharm Announce Strategic Partnership Agreement
Read article
26 Jun 2023
Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Read article
05 Jun 2023
JIXING Announces Completion of Patient Enrollment in China Cohort of Phase 3 Clinical Trial SEQUOIA-HCM of Aficamten
Read article
Load more
